We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

145 hedge funds and large institutions have $1.94B invested in Aegerion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 145 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $122M | Put options by funds: $90.3M

Holders
145
Holders Change
+145
Holders Change %
–
% of All Funds
4.73%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
145
Increased
–
Reduced
–
Closed
–
Calls
$122M
Puts
$90.3M
Net Calls
+$31.3M
Net Calls Change
+$31.3M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
76
Jane Street
New York
$1.9M +$1.59M +30,021 New
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$1.87M +$1.57M +29,502 New
LCG
78
Lisanti Capital Growth
New York
$1.8M +$1.04M +19,615 New
U
79
UBS
Switzerland
$1.75M +$1.47M +27,599 New
American Century Companies
80
American Century Companies
Missouri
$1.66M +$1.39M +26,145 New
WT
81
Whittier Trust
California
$1.63M +$1.37M +25,804 New
GACM
82
Green Arrow Capital Management
New York
$1.58M +$1.33M +25,000 New
MAA
83
Managed Account Advisors
New Jersey
$1.55M +$1.3M +24,412 New
ProShare Advisors
84
ProShare Advisors
Maryland
$1.51M +$1.27M +23,833 New
MLICM
85
Metropolitan Life Insurance Company (MetLife)
New York
$1.49M +$1.25M +23,571 New
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.42M +$1.19M +22,357 New
ST
87
Spot Trading
Illinois
$1.39M +$1.17M +21,986 New
AQR Capital Management
88
AQR Capital Management
Connecticut
$1.39M +$1.16M +21,934 New
RJA
89
Raymond James & Associates
Florida
$1.33M +$1.12M +21,069 New
SO
90
STRS Ohio
Ohio
$1.3M +$1.09M +20,500 New
Two Sigma Investments
91
Two Sigma Investments
New York
$1.29M +$1.08M +20,373 New
AIG
92
American International Group
New York
$1.23M +$1.03M +19,404 New
Swiss National Bank
93
Swiss National Bank
Switzerland
$1.16M +$972K +18,300 New
VOYA Investment Management
94
VOYA Investment Management
Georgia
$1.16M +$969K +18,253 New
FM
95
Forward Management
California
$1.09M +$1.25M +23,540 New
California Public Employees Retirement System
96
California Public Employees Retirement System
California
$1.08M +$908K +17,100 New
USAA
97
United Services Automobile Association
Texas
$1.08M +$908K +17,100 New
NTCOC
98
Northern Trust Company of Connecticut
Connecticut
$1.08M +$908K +17,101 New
DekaBank Deutsche Girozentrale
99
DekaBank Deutsche Girozentrale
Germany
$1.03M +$820K +15,450 New
BA
100
BlackRock Advisors
Delaware
$976K +$818K +15,409 New
2 3
4
5 6

AEGR Hedge Fund Activity: Q2 2013 in Review

145 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q2 2013, worth a combined $1.94B.

Buyers outnumbered sellers: 145 funds opened new AEGR positions and 0 closed out — a net gain of 145 holders — while 0 added to existing stakes and 0 trimmed.

  • 145 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.94B of Aegerion Pharmaceuticals stock for Q2 2013.
  • 145 funds opened new Aegerion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +145 holders.

Based on aggregated 13F filings for Q2 2013.